Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways
Statins inhibit the 3-hydroxy-3-methylglutaryl-CoA reductase enzyme and are the most widely used medication for hypercholesterolemia. Previous studies on the metabolite signature of simvastatin treatment have included only a small number of metabolites. We performed a high-throughput liquid chromato...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2022-08-01
|
| Serier: | Metabolites |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2218-1989/12/8/753 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|